argenx NV ADR

Yahoo Finance • 7 days ago

This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

Key Points RTW Investments established a new position in Apellis Pharmaceuticals, adding 7,666,764 shares during the fourth quarter. The quarter-end value of the Apellis stake was $192.59 million, reflecting the new position added by RTW... Full story

Yahoo Finance • 7 days ago

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch

RTW Investments disclosed a significant buy of Cogent Biosciences(NASDAQ:COGT) in its February 17, 2026, SEC filing, adding 4,124,755 shares in a trade estimated at $115.95 million based on quarterly average pricing. What happened Accord... Full story

Yahoo Finance • 12 days ago

Analysts Highlight Vyvgart Expansion as Major Growth Driver for Argenx (ARGX)

Argenx SE (NASDAQ:ARGX) ranks among the best growth stocks to buy and hold for the long term. Following the company’s Q4 results, Oppenheimer increased its price target for Argenx SE (NASDAQ:ARGX) to $1,060 from $1,040 on February 26 while... Full story

Yahoo Finance • 13 days ago

Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

Unnatural Products Inc. Financing led by The Venture Collective with participation from Merck Global Health Innovation Fund, Artis Ventures, First Spark Ventures, argenx, Droia Ventures and existing investors SANTA CRUZ, Calif., March 16... Full story

Yahoo Finance • 23 days ago

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with ocular MG Additional data from ADAPT SERON – the largest study of patients with gMG who do not have detectab... Full story

Yahoo Finance • 23 days ago

Oversold Conditions For argenx (ARGX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 25 days ago

Argenx Eyes Ocular Myasthenia Gravis To Deepen VYVGART Growth Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. argenx (ENXTBR:ARGX) reported positive topline data from its Phase 3 ADAPT OCULUS trial of VYVGART in ocular myasthenia gra... Full story

Yahoo Finance • last month

argenex Q4 Earnings Call Highlights

argenex logo 3 Healthcare Pathbreakers With Long-Term Tailwinds argenx (NASDAQ:ARGX) used its fourth-quarter earnings call to highlight positive Phase 3 data in ocular myasthenia gravis (MG), continued commercial momentum for VYVGART, an... Full story

Yahoo Finance • last month

argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis

Study met primary endpoint (p-value = 0.012) First registrational study to specifically evaluate a targeted treatment for patients living with ocular MG Results support planned Supplemental Biologics License Application (sBLA) submission t... Full story

Yahoo Finance • last month

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • last month

Artisan Mid Cap Fund Maintains Its Confidence in Argenx’s (ARGX) VYVGART

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise cha... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

European equities traded in the US as American depositary receipts were little changed late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Is argenx (ENXTBR:ARGX) Pricing Reflect Its DCF Upside After Recent Share Price Softness

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Wondering if argenx at €695.60 is priced for its story or for its... Full story

Yahoo Finance • 2 months ago

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 3 months ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More

mezzotint / Shutterstock.com Quick Read Stocks took another beating on Wednesday amid concerns over the AI/Data Center trade. While inflation appears somewhat contained, any spike in the headline number today could send markets lower. Ho... Full story

Yahoo Finance • 3 months ago

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week higher late M PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

ARGX Quantitative Stock Analysis - Benjamin Graham

Below is Validea's guru fundamental report for ARGENX SE - ADR (ARGX). Of the 22 guru strategies we follow, ARGX rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology... Full story

Yahoo Finance • 4 months ago

European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were higher late Tuesday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week

European equities traded in the US as American depositary receipts were trending higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story